14-3-3ζ结合aPKC-ι经上皮—间质细胞转化促进胆管癌侵袭转移
[Abstract]:Objective: To detect the expression of 14-3-3x2 and aPKC-_in cholangiocarcinoma and their relationship with clinical prognosis. Quantitative real-time polymerase chain reaction (qRT-PCR) and immunoblotting (WB) were used to detect the differential expression of 14-3-3, aPKC-_and E-cadherin in the tumor tissues and adjacent tissues of 64 patients with cholangiocarcinoma. In addition, 10 cases of cholangiocyst tissues were taken as negative control. Chi-square test and t-test were used to detect 14-3-3 and aPKC-_and cholangiocarcinoma. Correlation between pathological differentiation and TNM staging was analyzed by Spearman correlation analysis; Kaplan-Meier method was used to calculate the relationship between their expression and overall survival of patients with cholangiocarcinoma; Cox multivariate regression analysis was used to analyze independent prognostic factors in patients with cholangiocarcinoma. The expression of 14-3-3x2 and aPKC-_was positively correlated with the expression of E-cadherin, while the expression of 14-3-3x2 and aPKC-_was correlated with the pathological differentiation and TNM stage of cholangiocarcinoma. Cox multivariate regression analysis showed that 14-3-3_was an independent predictor of the prognosis of cholangiocarcinoma. Conclusion: 14-3-3_and aPKC-_co-promoted the occurrence, development, invasion and metastasis of cholangiocarcinoma, and 14-3-3_was an independent predictor of the prognosis of cholangiocarcinoma. The second part, 14-3-3 zeta and aPKC-_binding and mutual regulation purposes: Based on the first part of the study to further clarify the relationship between 14-3-3 zeta and aPKC-_. Methods: CO-IP experiment was used to detect whether 14-3-3 zeta and aPKC-_had specific direct binding relationship. Small molecule interference technology was used to synthesize 14-3-3 zeta. 3_-siRNA, aPKC-_-siRNA and aPKC-_overexpression vectors were constructed to construct stable 14-3-3_low expression vectors. The expression of aPKC-_and aPKC-_high expression human cholangiocarcinoma cell lines. Targeted silencing 14-3-3_or aPKC-_or aPKC-_-siRNA rescue experiments were performed by qRT-PCR, WB and IF detection. The results suggested that the expression of aPKC-_or 14-3-CO-IP 3_in the corresponding aPKC-_or aPKC-siRNA rescue experiments. WB could detect the corresponding aPKC-_and 14-3-3_protein bands in human cholangiocarcinoma tissues and cell proteins precipitated by 14-3-3_and aPKC-_antibodies; in vitro, the expression of aPKC-_or 14-3-3_decreased after targeted silencing of 14-3-3_or aPKC-_expression in human cholangiocarcinoma cells; and in aPKC-_-siRNA rescue experiment, the expression of aPKC-_-siRNA was accompanied by the decrease of aPKC-_-3-3 The expression of aPKC-_was restored and the expression of 14-3-3 was also elevated. Conclusion: 14-3-3 and aPKC-_were specifically and directly bound to each other in human cholangiocarcinoma. Part 3 14-3-3_-aPKC-_complex promotes epithelial-stromal cell transformation of cholangiocarcinoma cells METHODS: Human cholangiocarcinoma cell EMT model was established by TGF-beta 1 induction, and the expression of 14-3-3 ZE and aPKC-_in cholangiocarcinoma was regulated by small molecule interference technique and siRNA rescue experiment. The morphological changes of cells were observed by microscope, and the phenotype of EMT was detected by qRT-PCR, WB and IF. OBJECTIVE. RESULTS: EMT model of human cholangiocarcinoma cells induced by TGF-beta 1 was established in vitro. The morphological changes of the cells were observed as short spindle or triangle and polygonal shape as slender fibrous or long spindle. EMT markers: epithelioid phenotype E-cadherin and beta-catenin expression decreased, while mesenchymal phenotype N-cadherin and Vimentin expression increased. Then, when the expression of 14-3-3x2 or aPKC-_in human cholangiocarcinoma cells was silenced, the number of cells transformed into slender fibrous or long spindle shape was reduced by TGF-beta 1 stimulation, and the EMT markers did not change significantly. The results showed that the expression of 14-3-3 Zeta increased with the recovery of aPKC-_expression, and the changes of EMT markers appeared again. Conclusion: 14-3-3 Zeta promotes EMT transformation of human cholangiocarcinoma cells in vitro and in vivo by binding to aPKC-_to form a complex. Objective: To verify the effect of targeted silencing 14-3-3x2 on the proliferation and metastasis of cholangiocarcinoma in vitro and in vivo. Methods: Transwell invasion test, scratch test and clone plate test were used to verify the effect of targeted silencing 14-3-3x2 on the proliferation and metastasis of cholangiocarcinoma cells in vitro and subcutaneous transplantation of tumor in nude mice. In vivo, the proliferation and metastasis of cholangiocarcinoma cells were tested by targeting silencing 14-3-3x2. Results: In vitro, after targeting silencing 14-3-3x2, cholangiocarcinoma cells penetrated in the Transwell invasion test. The number of transbasement membrane cells decreased; the rate of cell migration decreased in scratch test; and the number of cell clones decreased in clone plate test. Conclusion: Targeted silencing of 14-3-3_in vitro can inhibit the invasion, metastasis and proliferation of cholangiocarcinoma cells, and may become a new target for the treatment of cholangiocarcinoma.
【学位授予单位】:华中科技大学
【学位级别】:博士
【学位授予年份】:2015
【分类号】:R735.8
【相似文献】
相关期刊论文 前10条
1 孟兴凯,杨成旺;胆管癌的诊断及治疗进展[J];内蒙古医学院学报;2002年02期
2 李蓉,蔡中起,张静;胆管癌诊治进展[J];临床肝胆病杂志;2002年04期
3 黎靖,冯春红,张旭,雷正明;胆管癌病理误诊一例[J];中华肝胆外科杂志;2003年09期
4 吴高松,罗先文,吴剑宏,邹声泉,裘法祖;先天性胆总管囊肿胆汁对胆管癌细胞系的作用[J];中华消化杂志;2004年01期
5 孔琦,黄强;胆管癌分子生物学研究进展[J];肝胆外科杂志;2004年05期
6 彭创;汤恢焕;;胆管癌的分子生物学进展[J];国际病理科学与临床杂志;2007年02期
7 李惠珍;Aqeel ahmed;傅华群;;胆管癌的早期诊断[J];江西医药;2008年12期
8 王健东;全志伟;;胆管癌基础研究现状[J];中国实用外科杂志;2008年04期
9 邹声泉;郑顺贞;;胆管癌分子生物学的研究现状及其意义[J];腹部外科;2008年02期
10 顾劲扬;仇毓东;周建新;丁义涛;;胆管癌发病机制及治疗进展[J];肝胆外科杂志;2010年05期
相关会议论文 前10条
1 周娉婷;房萌;高春芳;;胆管癌N糖标志物发现及其机制研究[A];第一次全国中西医结合检验医学学术会议暨中国中西医结合学会检验医学专业委员会成立大会论文汇编[C];2014年
2 张丰深;马宽生;何振平;董家鸿;;细胞凋亡相关基因与胆管癌临床病理的关系[A];2001'全国肿瘤外科学术会议论文汇编[C];2001年
3 张丰深;马宽生;何振平;董家鸿;;CCK、Gastrin对bcl-2基因家族的调节作用[A];2001'全国肿瘤外科学术会议论文汇编[C];2001年
4 余建华;崔云甫;;胆管癌发病机制研究进展[A];中国抗癌协会胆道肿瘤专业委员会成立大会暨第一届全国胆道肿瘤学术会议论文集[C];2009年
5 张丰深;马宽生;何振平;董家鸿;;CCK,Gastrin对凋亡基因的调节作用[A];第七届全国肿瘤生物治疗学术会议论文集[C];2001年
6 马宽生;张丰深;何振平;董家鸿;;CCK,Gastrin对胆管癌细胞凋亡的作用[A];第七届全国肿瘤生物治疗学术会议论文集[C];2001年
7 韩鹏;邱乒乒;戴燕燕;练惠辉;李文岗;陈清西;;河蚬活性物质对肝癌、胆管癌细胞生长的影响[A];华东六省一市生物化学与分子生物学会2008年学术交流会论文摘要汇编[C];2008年
8 李薇;曾祥元;李昆;;胆管癌QBC939细胞株对人脐静脉内皮细胞VEGF和b-FGF表达的影响[A];中国微循环学会2014年全国学术会议大会汇编[C];2014年
9 张昆松;梁力建;殷晓煜;;Wnt通路相关因子在胆管癌细胞系中的表达及其siRNA干扰实验[A];中国抗癌协会胆道肿瘤专业委员会成立大会暨第一届全国胆道肿瘤学术会议论文集[C];2009年
10 马宽生;张丰深;何振平;董家鸿;;CCK、Gastrin在beauvericin诱导胆管癌细胞凋亡中的作用[A];2001'全国肿瘤外科学术会议论文汇编[C];2001年
相关重要报纸文章 前2条
1 陈汉桥;大连医科大学附属一院胆管癌基因治疗研究获重要进展[N];中国医药报;2006年
2 陈汉桥;基因治胆管癌研究有进展[N];健康报;2006年
相关博士学位论文 前10条
1 杨辉;FBXW7抑制胆管癌上皮—间质转化、干细胞特性及转移的作用及机制研究[D];山东大学;2016年
2 戚大川;应用基因芯片筛选胆管癌相关差异表达基因及对其功能的研究[D];苏州大学;2015年
3 高云姝;PRR11在消化道肿瘤中的表达变化及其在胆管癌中的作用机制[D];青岛大学;2016年
4 赵鑫;B7-H4在胆管癌免疫逃逸中的作用和临床意义的初步研究[D];第三军医大学;2015年
5 李勇;CDC42过表达在胆管癌侵袭转移机制中的作用实验研究[D];第三军医大学;2015年
6 刘颜;aPKC-ι调控胆管癌细胞EMT及化疗抵抗作用中的机制研究[D];华中科技大学;2015年
7 杨彦;14-3-3ζ结合aPKC-ι经上皮—间质细胞转化促进胆管癌侵袭转移[D];华中科技大学;2015年
8 韩鹏;胆管癌药物的筛选及作用机理的研究[D];厦门大学;2009年
9 陈绍勤;胆管癌蛋白组学研究[D];华中科技大学;2009年
10 钱振宇;胆管癌与乙型和丙型肝炎病毒感染的相关性研究[D];复旦大学;2003年
相关硕士学位论文 前10条
1 董阳民;SENP1对胆管癌细胞增殖与徖移能力的影响以及SENP1在胆管癌标本中的表达情况[D];福建医科大学;2015年
2 朴鹤云;矢车菊素-3-葡萄糖苷对人胆管癌QBC939细胞的影响[D];延边大学;2015年
3 李志锋;骨桥蛋白与CD44v6在胆管癌中的表达及临床意义[D];河北医科大学;2015年
4 黄朝君;γ-氨基丁酸在胆管癌细胞中的作用机制及相关效应基因的探讨[D];安徽医科大学;2015年
5 薛立新;Hedgehog信号转导通路在胆管癌中作用机制初步研究[D];泸州医学院;2011年
6 赵殿堂;siRNA沉默Wip1基因对人胆管癌QBC939细胞的影响[D];山东大学;2015年
7 刘畅;醛酮还原酶家族1的C1亚型在胆管癌发生发展中作用及机制[D];第二军医大学;2015年
8 周娉婷;恶性胆胰肿瘤N糖组标志物和相关机制研究[D];第二军医大学;2015年
9 路健;烟碱型乙酰胆碱α7受体对胆管癌神经浸润的影响[D];青岛大学;2015年
10 谭永辉;ErbB4在胆管癌中的表达变化及作用研究[D];湖南师范大学;2015年
,本文编号:2207506
本文链接:https://www.wllwen.com/yixuelunwen/zlx/2207506.html